Warfarin: balancing the benefits and harms
作者： Marija Borosak
DOI: 10.18773/AUSTPRESCR.2004.074
关键词: Cardiology 、 Warfarin therapy 、 Venous thrombosis 、 Internal medicine 、 Intensive care medicine 、 Secondary prevention 、 Atrial fibrillation 、 Warfarin 、 Stroke 、 Medicine 、 Pharmacology (medical)
摘要: Summary The benefits of warfarin therapy are substantial in the prevention arterial and venous thrombosis, primary secondary stroke related to non-rheumatic atrial fibrillation. major risk is bleeding, which can cause significant morbidity or mortality. If bleeding high then alternatives therapeutic doses may be considered, although their efficacy suboptimal not eliminate bleeding. Constantly review patient’s circumstances order weigh up harms treatment with warfarin.
nps.org.au
sci-hub.st 参考文章(19)
F J M van der Meer, F R Rosendaal, J P Vandenbroucke, E Briët, Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants. Thrombosis and Haemostasis. ,vol. 76, pp. 12- 16 ,(1996) , 10.1055/S-0038-1650514
SP Myers, Interactions between complementary medicines and warfarin Australian Prescriber. ,vol. 25, pp. 54- 56 ,(2002) , 10.18773/AUSTPRESCR.2002.054
Paul Froom, Ehud Miron, Mira Barak, Oral anticoagulants in the elderly British Journal of Haematology. ,vol. 120, pp. 526- 528 ,(2003) , 10.1046/J.1365-2141.2003.04110.X
C. Seth Landefeld, Ohio Lee Goldman, Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy The American Journal of Medicine. ,vol. 87, pp. 144- 152 ,(1989) , 10.1016/S0002-9343(89)80689-8
Clive Kearon, Jeffrey S. Ginsberg, Michael J. Kovacs, David R. Anderson, Philip Wells, Jim A. Julian, Betsy MacKinnon, Jeffrey I. Weitz, Mark A. Crowther, Sean Dolan, Alexander G. Turpie, William Geerts, Susan Solymoss, Paul van Nguyen, Christine Demers, Susan R. Kahn, Jeannine Kassis, Marc Rodger, Julie Hambleton, Michael Gent, Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism The New England Journal of Medicine. ,vol. 349, pp. 631- 639 ,(2003) , 10.1056/NEJMOA035422
Malcolm Man-Son-Hing, Andreas Laupacis, Balancing the Risks of Stroke and Upper Gastrointestinal Tract Bleeding in Older Patients With Atrial Fibrillation JAMA Internal Medicine. ,vol. 162, pp. 541- 550 ,(2002) , 10.1001/ARCHINTE.162.5.541
D. G. Sherman, R. G. Hart, J. D. Easton, The secondary prevention of stroke in patients with atrial fibrillation. JAMA Neurology. ,vol. 43, pp. 68- 70 ,(1986) , 10.1001/ARCHNEUR.1986.00520010062024
Gualtiero Palareti, Jack Hirsh, Cristina Legnani, Cesare Manotti, Armando D'Angelo, Vittorio Pengo, Marco Moia, Giuliana Guazzaloca, Serena Musolesi, Sergio Coccheri, Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study. JAMA Internal Medicine. ,vol. 160, pp. 470- 478 ,(2000) , 10.1001/ARCHINTE.160.4.470
Elaine M. Hylek, Alan S. Go, Yuchiao Chang, Nancy G. Jensvold, Lori E. Henault, Joe V. Selby, Daniel E. Singer, Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. The New England Journal of Medicine. ,vol. 349, pp. 1019- 1026 ,(2003) , 10.1056/NEJMOA022913
Paul M Ridker, Samuel Z Goldhaber, Ellie Danielson, Yves Rosenberg, Charles S Eby, Steven R Deitcher, Mary Cushman, Stephan Moll, Craig M Kessler, C Gregory Elliott, Rolf Paulson, Turnly Wong, Kenneth A Bauer, Bruce A Schwartz, Joseph P Miletich, Henri Bounameaux, Robert J Glynn, None, Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism The New England Journal of Medicine. ,vol. 348, pp. 1425- 1434 ,(2003) , 10.1056/NEJMOA035029